Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Porcine placental extract is an animal tissue-derived placental extract prepared from pig placenta and used as a bioactive mixture rather than a single defined molecular entity. Publicly available literature describes it as containing multiple biologically active constituents and investigating it for metabolic and regenerative effects; in the provided publication context, it reduced lipid droplet accumulation during adipogenic differentiation and was associated with increased lysosomal acid lipase A expression and induction of autophagy-mediated lipophagy in adipose-derived mesenchymal stromal cells. It should be annotated as a nonspecific biological extract with incompletely defined composition and mechanism, rather than as a conventional single-agent pharmaceutical with a validated primary molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on porcine placental extract.